CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, D. R.
Right arrow Articles by Legault, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, D. R.
Right arrow Articles by Legault, S.
Related Collections
Right arrow General Anesthesia

Canadian Journal of Anesthesia, Vol 47, 943-949, Copyright © 2000 by Canadian Anesthesiologists' Society

ARTICLES

Cumulation characteristics of cisatracurium and rocuronium during continuous infusion

DR Miller, C Wherrett, K Hull, J Watson and S Legault
Department of Anesthesia, Ottawa Hospital, and University of Ottawa, Ontario, Canada. dmiller@ogh.on.ca

PURPOSE: The dissimilar pharmacokinetic properties of cisatracurium (CIS) and rocuronium (ROC) predict different potential for drug cumulation when these drugs are administered by continuous infusion. A study was therefore undertaken to compare cumulation potential of CIS and ROC during surgical procedures of relatively long duration (2-4 hr). METHODS: Sufentanil/propofol-N2O anesthesia was administered to 40 ASA I and II adults. In a double-blind protocol, patients were randomly allocated to receive a continuous i.v. infusion of either CIS or ROC, titrated in progressive increments or decrements as required to achieve and maintain 95 +/- 5% depression of the T1 response of the adductor pollicis muscle, using a Datex NMT-100 Relaxograph EMG monitor applied at the wrist. At the end of surgery, 60 microg x kg(-1) neostigmine plus 15 microg x kg(-1) atropine were administered for reversal. RESULTS: The duration of infusion was 104 +/- 33 min in group CIS and 110 +/- 23 min in group ROC (P=NS). In both groups, a progressive decrease in potency-adjusted infusion rates was observed after 30 min, then stabilized beyond 60 min. When allowing for an initial period of stabilization, mean potency-adjusted infusion requirements were: CIS 0.81 +/- 0.02 microg x kg(-1) x min(-1) and ROC 5.58 +/- 1.94 microg x kg(-1) x min(-1). There were no differences between groups at any time with regard to potency-adjusted infusion requirements necessary to maintain 90-99% block (P=NS). However, drug costs/hr for maintenance of neuromuscular block were less with CIS ($3.57 +/- 0.09) than with ROC ($6.03 +/- 0.27), P < 0.001. CONCLUSION: When adjusted to equipotency, infusion requirements of CIS and ROC vary at similar rates during general anesthesia. Despite pharmacokinetic differences, neither drug demonstrates cumulation for infusion lasting up to 3.5 hr.


This article has been cited by other articles:


Home page
 Canadian J. AnesthesiaHome page
C. Motamed and F. Donati
Sevoflurane and isoflurane, but not propofol, decrease mivacurium requirements over time : [Le sevoflurane et l'isoflurane, mais pas le propofol, diminuent les besoins en mivacurium avec le temps]
Can J Anesth, November 1, 2002; 49(9): 907 - 912.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
F Donati
Cumulation and flexibility with infusions of neuromuscular blocking drugs
Can J Anesth, October 1, 2000; 47(10): 936 - 942.



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Canadian Anesthesiologists' Society.